World Marine Derived Drugs Market Forecast 2017-2027

LONDON, October 4, 2017 /PRNewswire/ --

Prospects by Drug Type (Phenol, Steroid, Ether, Peptide, Other), Source (Algae, Invertebrate, Microorganism), Application (Anti-Microbial, Anti-Tumour, Cardiovascular, Anti-Viral, Anti-Inflammatory), and Geography

Marine Derived Drugs - our new study reveals trends, R&D progress, and predicted revenues
     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

Where is the Marine Derived Drugs market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead
Our 172-page report provides 161 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Marine Derived Drugs market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 3 segmentations of the marine-derived drugs market, with forecasts for 4 Marine Derived Drug Types, 3 Sources and 5 Applications, each forecasted at a global and regional level.

Global Marine-Derived Drugs Market by Type
• Steroid
• Ether
• Peptide
• Other 

Global Marine-Derived Drugs Market by Source
• Algae
• Invertebrates
• Microorganisms 

Global Marine-Derived Drugs Market by Application
• Anti-microbial
• Anti-tumour
• Anti-cardiovascular
• Anti-viral
• Anti-inflammatory
• Other 

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 regional and 17 leading national markets:

• North America:
• US
• Canada
• Mexico

• South America:
• Brazil
• Argentina
• Paraguay
• Bolivia
• Rest of South America

• Europe:
• Germany
• The UK
• Italy
• Spain
• France
• Rest of Europe

• Asia-Pacific:
• Japan
• China
• India
• Australia
• Thailand
• Rest of Asia-Pacific

• Rest of the World:
• Middle East
• Africa
• Other Countries

The report also includes profiles and for some of the leading companies in the Marine Derived Drugs market, with a focus on this segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and Australia in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth
Overall world revenue for Marine Derived Drugs will surpass $9.3bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Marine Derived Drugs Market report helps you
In summary, our 172-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for 3 segmentations of the marine-derived drugs market, with forecasts for 4 Marine Derived Drug Types, 3 Sources and 5 Applications, each forecasted at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 7 regional and 17 key national markets - See forecasts for the marine-derived drugs market in North America, South America, Europe, Asia-Pacific, the Middle East, Africa and Other Countries. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Bolivia, Paraguay, Germany, France, the UK, Italy, Spain, China, India, Japan, Australia and Thailand
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Marine Derived Drugs market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Marine Derived Drugs market and leading companies. You will find data, trends and predictions.

Get our report today World Marine Derived Drugs Market Forecast 2017-2027: Prospects by Drug Type (Phenol, Steroid, Ether, Peptide, Other), Source (Algae, Invertebrate, Microorganism), Application (Anti-Microbial, Anti-Tumour, Cardiovascular, Anti-Viral, Anti-Inflammatory), and Geography.

To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100.

Or click on https://www.visiongain.com/Report/2008/World-Marine-Derived-Drugs-Market-Forecast-2017-2027

Companies Mentioned in the Report 

Abbott Laboratories

AbbVie, Inc.

Alkermes Plc

Amarin Corp. Plc

Amgen, Inc.

Amnis Corporation

Aphios Corporation

Array BioPharma, Inc.

Associates Of Cape Cod  Inc.

Astex Pharmaceuticals  Inc.

AstraZeneca Plc

ASYMPTOTE LTD

Bayer AG

Bayer Corporation

Bayer HealthCare AG

Bayer Schering Pharma Aktiengesellschaft

BioMarin Pharmaceutical, Inc.

Biotest AG

Bristol-Myers Squibb Co.

Cardax, Inc.

Ceapro, Inc.

Celgene Corp.

Centene Corp.

Cephalon, Inc.

Chugai Pharmaceutical Co., Ltd.

CK Life Sciences International (Holdings), Inc.

CTI BioPharma Corp.

Deroyal Industries  Inc.

Domain Therapeutics SA

Emd Millipore Corporation

Emd Serono  Inc.

Endo International Plc

Evotec AG

GE HEALTHCARE LTD

GlaxoSmithKline Plc

Henry Schein, Inc.

International Medical Corps

Janssen Biotech, Inc.

JHL Biotech, Inc.

Johnson & Johnson

Laboratoire Theramex

Lombard Medical, Inc.

Lonza Group AG

Marine Polymer Technology

Medtronic Plc

Merck KGaA

MorphoSys AG

Myrexis, Inc.

NBTY, Inc.

Neptune Technologies & Bioresources, Inc.

Nexvet Biopharma PLC

Nordion Inc

Novartis AG

Opexa Therapeutics, Inc.

Otsuka Pharmaceutical Co.  Ltd.

Panacos Pharmaceuticals, Inc.

PELICAN HEALTHCARE LTD

Pfizer Inc.

Pharma Mar SA

Polymer Technology Systems  Inc.

Premier Healthcare Alliance  L.P.

Progyny Inc.

Quanterix Corp.

Samsung BioLogics Co., Ltd.

Sangers (Northern Ireland) Limited

Sanofi

Sea Run Holdings

Spectrum Pharmaceuticals, Inc.

T G EAKIN LTD

Taiho Pharmaceutical Co.  Ltd.

Takeda Pharmaceutical Co., Ltd.

UnitedHealth Group, Inc.

Verastem, Inc.

Vertex Pharmaceuticals, Inc.

VWR International, LLC

Windtree Therapeutics, Inc.

Zogenix, Inc.

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com